XML 109 R96.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Dec. 06, 2021
Dec. 06, 2021
Sep. 20, 2021
Sep. 02, 2021
Feb. 02, 2021
Jan. 14, 2021
Jan. 07, 2021
Mar. 23, 2022
Dec. 31, 2021
Dec. 31, 2020
Aug. 19, 2021
Subsidiary, Sale of Stock [Line Items]                      
Warrant exercise price                     $ 3.25
Percentage for placement agent received discount and commissions         6.00% 6.00%          
Proceeds from Issuance Initial Public Offering                 $ 13,346,600  
Shares price                 $ 1.14    
Shares vested               5,000      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period                 7,700    
Number of repurchased shares 2,163,341                    
Number of repurchase $ 2,312,054                    
Cancellation of treasury stock                 63,518    
Net income attributable to noncontrolling interests of consolidated subsidiary                 $ 56,453  
Nobility Healthcare LLC [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Ownership percentage                 51.00%    
Minority interest rate                 49.00%    
Stock Repurchase Program [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Number of repurchased shares                 1,734,838,000,000    
Goody Tickets LLC and Ticket Smarter LLC [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Stock Issued During Period, Shares, Acquisitions       719,738              
Officers [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Common stock issuance granted     406,000       450,000        
Vesting drescription             Such shares will generally vest one-half on January 7, 2022, and one half on January 7, 2023, provided that each grantee remains an officer or employee on such dates        
Shares vested     26,000                
Number of shares expected to vest     380,000                
Vesting period     5 years                
Maximum [Member] | Stock Repurchase Program [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Proceeds from common stock   $ 10,000,000.0                  
Warrant [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Shares price         $ 3.25 $ 3.25          
Cancellation of treasury stock                 1,679,766 5,000  
Underwritten Public Offering [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Equity method investment pwnership percentage description           On January 14, 2021, the Company consummated a registered direct offering (the “Offering”) of (i) 2,800,000 shares of common stock (“Shares”), (ii) pre-funded warrants to purchase up to 7,200,000 shares of Common Stock (the “Pre-Funded Warrants”), issuable to investors whose purchase of shares of Common Stock would otherwise result in such investor, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding Common Stock immediately following the consummation of the Registered Offering (“Pre-Funded Warrants”); and (iii) common stock purchase warrants (“Warrants”) to purchase up to an aggregate of 10,000,000 shares of Common Stock (the “Warrant Shares”), which are exercisable for a period of five years after issuance at an initial exercise price $3.25 per share, subject to certain adjustments, as provided in the Warrants          
Stock issued during period, shares, new issues           2,800,000          
Warrants to purchase shares           10,000,000          
Warrants and rights outstanding, term           5 years          
Warrant exercise price           $ 3.25          
Shares price           $ 3.095          
Underwritten Public Offering [Member] | Pre Funded Warrants [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Warrants to purchase shares           7,200,000          
IPO [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Equity method investment pwnership percentage description         the Company consummated an registered direct offering (the “Second Offering”) of (i) 3,250,000 shares of common stock (“Shares”), (ii) pre-funded warrants to purchase up to 11,050,000 shares of Common Stock (the “Pre-Funded Warrants”), issuable to investors whose purchase of shares of Common Stock would otherwise result in such investor, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding Common Stock immediately following the consummation of the Registered Offering (“Pre-Funded Warrants”); and (iii) common stock purchase warrants (“Warrants”) to purchase up to an aggregate of 14,300,000 shares of Common Stock (the “Warrant Shares”), which are exercisable for a period of five years after issuance at an initial exercise price $3.25 per share, subject to certain adjustments, as provided in the Warrants            
Stock issued during period, shares, new issues         3,250,000 2,800,000          
Warrants to purchase shares         14,300,000            
Warrants and rights outstanding, term         5 years            
Warrant exercise price         $ 3.25            
Shares price         $ 2.80 $ 3.095          
Percentage of right to participate in subsequent offering         50.00% 50.00%          
Proceeds from Issuance Initial Public Offering           $ 28,941,000          
Shares price                   $ 1.15  
IPO [Member] | Maximum [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Warrants to purchase shares           10,000,000          
IPO [Member] | Pre Funded Warrants [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Warrants to purchase shares         11,050,000 7,200,000          
Shares price         $ 2.79 $ 3.085          
Proceeds from Issuance Initial Public Offering         $ 37,447,100 $ 29,013,000          
Shares price         $ 2.79            
Shares price         $ 2.80            
IPO [Member] | Pre Funded Warrants [Member] | Maximum [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Warrants to purchase shares         14,300,000            
Proceeds from Issuance Initial Public Offering         $ 37,557,600